NCT06513728

Brief Summary

Examine the preliminary effect of the MPACT intervention on methadone treatment retention, in treatment overdose and patient trauma symptoms. The study will also explore the relationship between staff trauma symptoms and MPACT implementation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 22, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

September 26, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

August 8, 2025

Status Verified

May 1, 2025

Enrollment Period

7 months

First QC Date

July 16, 2024

Last Update Submit

August 4, 2025

Conditions

Keywords

Implementation ScienceMethadone treatmentOpioid Use DisorderOpioid Use Disorder TreatmentWorkforce DevelopmentVicarious traumaPosttraumatic stressTreatment retention

Outcome Measures

Primary Outcomes (2)

  • methadone treatment retention

    Retention in methadone treatment (measured by 3 different indicators)

    4 months (pilot study period)

  • In treatment overdose

    Reported overdoses during methadone treatment (measured by study constructed algorithm)

    4 months (pilot study period)

Secondary Outcomes (2)

  • Trauma symptoms among patients and staff

    pilot period of 4 months

  • Vicarious Trauma symptoms among staff

    pilot period of 4 months

Study Arms (1)

MPACT Intervention

EXPERIMENTAL

Single arm study. All sites will receive the intervention.

Other: MPACT Intervention

Interventions

MPACT has 4 components: accredited training about patient centered, trauma informed methadone treatment, staff education about trauma symptoms with navigation to self screening and treatment or stress management, clinic self assessment tools for trauma informed, patient centered care, and reflective supervision for counselors, case managers and peer staff.

MPACT Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Staff of enrolled opioid treatment programs (methadone clinics) who are involved with methadone treatment
  • Patients receiving methadone at these locations

You may not qualify if:

  • Patients not receiving methadone at these locations
  • Staff not involved in methadone treatment at these locations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arizona College of Medicine

Tucson, Arizona, 85714, United States

Location

Related Publications (1)

  • Meyerson BE, Davis A, Crosby RA, Linde-Krieger LB, Brady BR, Carter GA, Mahoney AN, Frank D, Rothers J, Coffee Z, Deuble E, Ebert J, Jablonsky MF, Juarez M, Lee B, Lorenz HM, Pava MD, Tinsely K, Yousaf S. Methadone Patient Access to Collaborative Treatment: Protocol for a Pilot and a Randomized Controlled Trial to Establish Feasibility of Adoption and Impact on Methadone Treatment Delivery and Patient Outcomes. JMIR Res Protoc. 2025 Apr 15;14:e69829. doi: 10.2196/69829.

MeSH Terms

Conditions

Opioid-Related DisordersCompassion Fatigue

Condition Hierarchy (Ancestors)

Narcotic-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental DisordersMental FatigueFatigueSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehaviorOccupational StressStress, Psychological

Study Officials

  • Beth Meyerson, PhD

    Professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: This is a pilot implementation and preliminary effectiveness study of MPACT.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 16, 2024

First Posted

July 22, 2024

Study Start

September 26, 2024

Primary Completion

April 30, 2025

Study Completion

April 30, 2025

Last Updated

August 8, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

A Data Sharing and Management Plan was submitted to NIDA for this study. please see that submission.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
1 year after the study completion
Access Criteria
See Data sharing and management plan

Locations